Review
Establishing the safety of influenza vaccine in egg-allergic individuals
Matthew J Greenhawt. Pediatr Ann. 2013 Jul.
Abstract
CME EDUCATIONAL OBJECTIVES 1. Understand that trivalent influenza vaccine is safe for patients with egg allergy, including patients with severe egg allergy. 2. Understand that egg-allergic patients no longer require any special precautions to safely receive trivalent influenza vaccine. 3. Recognize that the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices advises that most egg-allergic patients can now receive trivalent influenza vaccine from their primary care physician. Trivalent influenza vaccine is grown in chick embryos and contains residual egg protein [ovalbumin]. Historically, trivalent influenza vaccine [TIV] has been contraindicated in egg-allergic individuals [EAI] and the vaccine was withheld in many of these individuals due to the ovalbumin. However, protocols were developed that allowed EAIs to safely receive TIV, including stepwise desensitization, vaccine skin testing, and use of low ovalbumin containing vaccine. In the past 3 years, several groups have systematically disproven that EAI are at any increased risk for an allergic reaction than the general population and withholding TIV is not necessary. To date, approximately 4,315 patients have safely received 4,872 total doses of TIV, including 656 EAI with severe egg allergy [including anaphylaxis to egg] who safely received 740 doses of TIV. Thus, it is as safe to provide TIV to EAI as providing it to a non-EAI. This article will trace the evolution of this practice.
Copyright 2013, SLACK Incorporated.
Similar articles
Physician compliance with updated practice parameters for influenza vaccination in individuals with egg allergies.
Greenhawt M, Wang J. Greenhawt M, et al. J Allergy Clin Immunol Pract. 2013 Nov-Dec;1[6]:602-7. doi: 10.1016/j.jaip.2013.07.007. Epub 2013 Sep 25. J Allergy Clin Immunol Pract. 2013. PMID: 24565707
Coordination of multidisciplinary resources for vaccination of egg-allergic individuals during an H1N1 [novel] influenza pandemic.
Pien GC, LeBenger KS, Carotenuto DR, Difilippi M, Scolpino D, Simmons JM, Barrett C, Brenner RW. Pien GC, et al. Allergy Asthma Proc. 2010 Nov-Dec;31[6]:507-10. doi: 10.2500/aap.2010.31.3396. Epub 2010 Oct 12. Allergy Asthma Proc. 2010. PMID: 20943012
Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy.
Greenhawt MJ, Spergel JM, Rank MA, Green TD, Mansoor D, Sharma H, Bird JA, Chang JE, Parikh DS, Teich E, Kelso JM, Sanders GM. Greenhawt MJ, et al. Ann Allergy Asthma Immunol. 2012 Dec;109[6]:426-30. doi: 10.1016/j.anai.2012.09.011. Epub 2012 Oct 24. Ann Allergy Asthma Immunol. 2012. PMID: 23176882 Clinical Trial.
Influenza immunization in egg allergy: an update for the 2011-2012 season.
Erlewyn-Lajeunesse M, Lucas JS, Warner JO. Erlewyn-Lajeunesse M, et al. Clin Exp Allergy. 2011 Oct;41[10]:1367-70. doi: 10.1111/j.1365-2222.2011.03842.x. Clin Exp Allergy. 2011. PMID: 22073922 Review.
Administering influenza vaccine to egg-allergic persons.
Kelso JM. Kelso JM. Expert Rev Vaccines. 2014 Aug;13[8]:1049-57. doi: 10.1586/14760584.2014.933079. Epub 2014 Jun 25. Expert Rev Vaccines. 2014. PMID: 24962036 Review.
Cited by
Safety of Inactivated Influenza Vaccine in Patients with Egg Allergy in Kurdistan Province, Iran.
Tozandehjani S, Nasiri Kalmarzi R, Khodabandehloo M, Kashefi H. Tozandehjani S, et al. Iran J Public Health. 2019 Apr;48[4]:758-763. Iran J Public Health. 2019. PMID: 31110987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal